Abstract:Objective To explore the value of peripheral blood high mobility group protein B1 (HMGB1) and platelet activating factor (PAF) levels in predicting the short-term prognosis of patients with septic shock.Methods A total of 85 patients with septic shock admitted to the hospital from May 2018 to May 2021 were selected. The general clinical data of all patients were collected and the levels of HMGB1 and PAF before the treatment were detected. After the treatment, the patients were followed up for 28 days and their survival status was recorded. Factors affecting the short-term prognosis of patients with septic shock were determined. The value of HMGB1 and PAF levels in predicting the short-term prognosis of patients with septic shock was analyzed.Results During the follow-up, 28 of 85 patients with septic shock died, and the rest 57 survived. The multivariable Logistic regression analysis showed that the Acute Physiology and Chronic Health Evaluation II (APACHE II) score [O^R = 5.441 (95% CI: 2.392, 12.378) ], oxygenation index [O^R = 4.577 (95% CI: 2.012, 10.411) ], HMGB1 level [O^R = 4.341 (95% CI: 1.908, 9.874) ], and PAF level [O^R = 4.491 (95% CI: 1.974, 10.215) ] were independent factors affecting the short-term prognosis of patients with septic shock (P < 0.05). The ROC curve analysis revealed that the sensitivities of HMGB1, PAF and the combination of the two for predicting the short-term prognosis of patients with septic shock were 71.43%, 75.00% and 71.43%, the specificities were 70.18%, 73.68% and 89.47%, and the areas under the ROC curves (AUCs) were 0.752, 0.764 and 0.879, respectively.Conclusions Patients with septic shock have a higher risk of poor prognosis. HMGB1 and PAF levels are related to the short-term prognosis of patients with septic shock. The combination of the two shows great efficacy in predicting the prognosis of patients with septic shock.